Key Words: apurinic/apyrimidinic endonuclease-1/redox factor-1 Ⅲ vascular smooth muscle cells Ⅲ migration Ⅲ reactive oxygen species Ⅲ spleen tyrosine kinase P latelet-derived growth factor (PDGF) performs crucial functions in the regulation of vascular cell proliferation and migration, resulting in circulatory disorders including atherosclerosis. PDGF stimulates intracellular signal molecules with Src homology 2 (SH2) domains, including Src, phospholipase C, phosphatidylinositol 3-kinase (PI3K), and ras/raf-1. 1,2 Src, PI3K, and phospholipase C␥ perform crucial functions related to actin reorganization, growth, and migration in response to PDGF in the vascular smooth muscle cells, 3 and these activities are mediated by the activation of a family of serine/threonine-specific protein kinases, the mitogen-activated protein kinases (MAPK), most notably p38 MAPK. 4 Recently, we determined that spleen tyrosine kinase (Syk), a 70-kDa non-receptor protein tyrosine kinase harboring 2 SH2 domains, binds to phosphorylated PDGF receptor (PDGF-R) and contributes to PDGF-mediated migration in the vascular smooth muscle. 5 Moreover, PDGF-R transmits its signal into intracellular space with the production of reactive oxygen species (ROS), particularly superoxide (O Ϫ⅐ ) and hydrogen peroxide (H 2 O 2 ). 6,7 PDGF augments O Ϫ⅐ levels through NADPH oxidase (NOX), and the inhibition of NOX activity reduces PDGF-induced chemotaxis in vascular smooth muscle cells. 8, 9 Because ROS perform crucial functions in many aspects of cellular function, the redox system can be implicated in the regulation of vascular dysfunction. Furthermore, ROS stimulates PDGF-R phosphorylation. 10 These results indicate that ROS may be involved in the activation of PDGF-R via ROS-activated protein kinases.
P latelet-derived growth factor (PDGF) performs crucial functions in the regulation of vascular cell proliferation and migration, resulting in circulatory disorders including atherosclerosis. PDGF stimulates intracellular signal molecules with Src homology 2 (SH2) domains, including Src, phospholipase C, phosphatidylinositol 3-kinase (PI3K), and ras/raf-1. 1,2 Src, PI3K, and phospholipase C␥ perform crucial functions related to actin reorganization, growth, and migration in response to PDGF in the vascular smooth muscle cells, 3 and these activities are mediated by the activation of a family of serine/threonine-specific protein kinases, the mitogen-activated protein kinases (MAPK), most notably p38 MAPK. 4 Recently, we determined that spleen tyrosine kinase (Syk), a 70-kDa non-receptor protein tyrosine kinase harboring 2 SH2 domains, binds to phosphorylated PDGF receptor (PDGF-R) and contributes to PDGF-mediated migration in the vascular smooth muscle. 5 Moreover, PDGF-R transmits its signal into intracellular space with the production of reactive oxygen species (ROS), particularly superoxide (O Ϫ⅐ ) and hydrogen peroxide (H 2 O 2 ). 6, 7 PDGF augments O Ϫ⅐ levels through NADPH oxidase (NOX), and the inhibition of NOX activity reduces PDGF-induced chemotaxis in vascular smooth muscle cells. 8, 9 Because ROS perform crucial functions in many aspects of cellular function, the redox system can be implicated in the regulation of vascular dysfunction. Furthermore, ROS stimulates PDGF-R phosphorylation. 10 These results indicate that ROS may be involved in the activation of PDGF-R via ROS-activated protein kinases.
Despite these reports, the mechanisms underlying the relationship between PDGF-R signaling and ROS remain to be clearly elucidated.
Apurinic/apyrimidinic endonuclease/redox factor-1 (Ref-1) is a ubiquitous multifunctional protein that is involved in the base excision repair pathways of DNA subjected to oxidative damage. 11 In addition, Ref-1 also promotes a variety of redoxmediated events regulating cell growth, differentiation, survival, and death, which are associated with activator protein-1, nuclear factor B, p53, Egr-1, and cMyb. 12, 13 Ref-1 has been reported to inhibit the activation of Rac-1, an essential cofactor for the NOX complex. This results in the inhibition of NOX, thereby reducing the level of ROS and endothelial cell growth and migration. 14 has been demonstrated to suppress intracellular oxidative stress and apoptosis via the modulation of Rac-1-regulated oxidation. 15 We previously showed that tumor necrosis factor ␣-stimulated inflammation was inhibited by Ref-1 overexpression in vascular endothelial cells. 16 Moreover, Ref-1 expression was upregulated as a consequence of ROS treatment and in atherosclerotic plaques. 14, 17 The finding that Ref-1 contributes to the regulation of PDGF-stimulated proliferation suggests a possible role for Ref-1 in vascular smooth muscle dysfunction. 18 However, the roles of Ref-1 in smooth muscle cell migration have yet to be fully determined. Therefore, in this study, we attempted to determine the role of Ref-1 on PDGF-induced migration and balloon-injured carotid arteries and its signaling associated with ROS production using rat aortic smooth muscle cells (RASMCs) transfected with adenoviruses encoding for full-length Ref-1 (AdRef-1).
Materials and Methods
An expanded Materials and Methods section is available in the online data supplement at http://circres.ahajournals.org.
Cell Culture, Immunoblotting, and Immunoprecipitation
Our investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the (NIH Publication No. 85-23, revised 1996) . All experiments and animal care were conducted in conformity with the institutional guidelines established by Konkuk University, South Korea. RASMCs (used at passages 5 to 9) were isolated via treatment with enzymes from male Sprague-Dawley rats (6 weeks old; 190 g; nϭ6), which were purchased from Daehanbiolink (Chungju, South Korea). Cell culture, immunoblotting, and immunoprecipitation were performed as previously described. 5 
Adenoviral Transfection
Adenoviruses encoding for ␤-galactosidase (Ad␤-gal) and fulllength human AdRef-1 were generated via homologous recombination in human embryonic kidney 293 cells, as previously described. 19 RASMCs were infected for 2 hours in 2% FBS-DMEM at a multiplicity of infection (moi) (particle-forming units per cell) of 200 of the specified adenovirus and subsequently incubated for 36 hours in normal DMEM with the virus. The virus was then removed and the cells were incubated for 18 hours in FBS free DMEM, followed by experimental treatments or assays. After adenoviral transfection, the efficiency of transfection obtained in the endothelial cells was Ϸ90%.
Cell Migration, Proliferation Assay, and Superoxide Production
Cell migration was assessed with 48-well microchemotaxis Boyden chambers (Neuro Probe, Gaithersburg, Md) as described previously. 5 Cell proliferation was determined via a 5-bromo-2Ј-deoxyuridine (BrdUrd) incorporation assay (Roche, Indianapolis, Ind). O Ϫ⅐ production was measured via lucigenin-enhanced chemiluminescence. 8 
Rac-1 Pull-Down Assay
RASMCs (2ϫ10 5 cells) were treated with stimulants or inhibitors and washed with ice-cold PBS, incubated for 5 minutes on ice in the extraction buffer, then centrifuged for 15 minutes at 16 000g at 4°C. Aliquots were obtained from the supernatant for comparisons of protein content. The supernatant proteins were incubated for 60 minutes with the bacterially produced GST-PAK fusion protein (Cytoskeleton, Denver, Colo) harboring the Rac-1 binding region, bound to glutathione-coupled sepharose beads at 4°C. The beads and proteins bound to the fusion protein were then washed 3 times in an excess of lysis buffer, eluted in Laemmli sample buffer (60 mmol/L Tris, pH 6.8, 2% SDS, 10% glycerin, 0.1% bromphenol blue), and analyzed for bound Rac-1 molecules via Western blotting.
Aortic Ring Assay, Balloon Injury, and Adenoviral Gene Transfer
Ex vivo RASMC migration was assessed via an aortic ring assay using modified Matrigel. 5 Male Sprague-Dawley rats (350 to 400 g) were anesthetized using a ketamine (80 mg/kg)/xylazine (12 mg/kg) mixture, and the left common and external carotid arteries were exposed and isolated. A 2F Fogarty catheter (Edwards Lifesciences, Irvine, Calif) was introduced into the common carotid artery through arteriotomy in the external carotid artery and inflated to 1.0 to 1.5 atmospheres, and a 10-mm injury was induced by withdrawn 4 times. After balloon removal, 100-L aliquots of PBS containing Ad␤-gal (1ϫ10 9 particles; nϭ4) or AdRef-1 (1ϫ10 9 particles; nϭ6) were injected through a cannula and allowed to incubate in the injured segment for 30 minutes. The external carotid was then tied and the blood flow was restored. Animals were euthanized after 2 weeks. Media and neointima areas of injured arteries were quantified by planimetry (m 2 ) and intima-to-media ratios were calculated.
Transfection Small Interference RNA
Small interference (si)RNA was designed to target the sequences of rat Ref-1 (5Ј-CAAACUUCUGGUUUCCUUU-3Ј; accession no. NM_024148). The RNA of 19 nucleotides followed by TT were designed and chemically synthesized, purified, and annealed. Nonsilencing siRNA (5Ј-CCUACGCCACCAAUUUCGU-3Ј) was provided by Bioneer (Korea).
Statistical Analysis
Data were expressed as the meansϮSE of the mean. The data were statistically evaluated using Student's t tests for comparisons between pairs of groups and by ANOVA for multiple comparisons. A probability value of Ͻ0.05 was considered be statistically significant.
Results

Ref-1 on PDGF-BB-Induced Migration in RASMCs
We first assessed the levels of adenoviral-mediated Ref 
Ref-1 on the Phosphorylation of Syk and the Binding of PDGF␤-R to Syk
We recently showed that Syk regulates PDGF-BB-induced migration via the p38 MAPK/heat shock protein (Hsp)27 pathway in RASMCs. 5 Thus, we attempted to determine 
Ref-1 and NOX Inhibitor on the Phosphorylation of PDGF␤-R
It was reported that PDGF-induced ROS production mediated by NOX, and PDGF-BB-induced migration was reduced by the inhibition of NOX in vascular smooth muscle cells. 8, 9 We determined whether treatment with an antioxidant and NOX inhibitors would affect the PDGF-BB-induced RASMC phosphorylation of PDGF␤-R. As is shown in Figure 5A and 5C, PDGF-BB (10 ng/mL) induced an increase in PDGF␤-R phosphorylation, which was inhibited by treatment with DPI (10 mol/L), apocynin (1 mmol/L), and NAC (10 mmol/L). We also assessed the influence of Syk inhibitor on PDGF␤-R activation. PDGF-BB (10 ng/mL) enhanced PDGF␤-R activity in RASMCs, and this was abolished completely as the result of treatment with 30 mol/L piceatannol ( Figure 5B  and 5D ). We then attempted to determine the effects of Ref-1 on PDGF␤-R activation. As is shown in Figure 5E , transfection with AdRef-1 (200 mois) partially inhibited the increase in PDGF␤-R phosphorylation induced by PDGF-BB (10 ng/mL), but transfection with Ad␤-gal (200 mois) did not.
Effects of Ref-1 Knockdown in PDGF-Induced Responses
To Matrigel. The rings were embedded in Matrigel, and sprout outgrowth was assessed in terms of cell migration and proliferation. As is shown in Figure 7A and supplemental Figure I , B, PDGF-BB (10 ng/mL) effected an increase in the sprout growth of the aortic rings, and this effect was attenuated by treatment with AdRef-1 (200 mois), but not by treatment with Ad␤-gal (200 mois).
Effect of Gene Transfer of AdRef-1 on Neointimal Formation
To It has been suggested that the ROS generated by NOX activation can stimulate growth factor receptors. 23 The elevation of intracellular ROS levels as the result of PDGF-R activation was found to be the cause of full receptor activation in certain cells, most notably vascular smooth muscle cells. 10, 24 Moreover, the treatment of cells with NOX inhibitor or catalase resulted in the inhibition of PDGF-R phosphorylation. 8 In this study, we determined that the inhibition of NOX activity and ROS scavenging inhibited, although not completely, the phosphorylation of PDGF␤-R in response to PDGF-BB. These results indicate that initial levels of ROS released as the result of PDGF stimulation may participate in the regulation of PDGF-R activity. Moreover, ROS directly stimulate intracellular signals activated by PDGF stimulation. It was recently determined that Src is dually regulated; firstly, by its direct stimulation of PDGF-R, and secondly, by the ROS production induced by PI3K-and protein kinase C-mediated NOX activation. 8 Furthermore, in both the present study and previous reports, PDGF was demonstrated to increase the phosphorylation of Syk, and this effect was inhibited by ROS inhibitors or Ref-1 transfection. 5 By way of contrast, Syk kinase inhibitor effected the complete abolition of PDGF-R activity in response to PDGF-BB. Syk is activated by ROS in lymphoma cells. 25 Moreover, ROS have been shown to regulate a protein tyrosine phosphatase (PTP), SHP-2, resulting in the activity of proteins that harbor the SH2 domain, including Syk. 26 According to these results, it can be surmised that ROS stimulates Syk activity via PTP in vascular smooth muscle cells. In the present study, Syk activity was partly inhibited in Ref-1-transfected cells. These results indicate that Syk kinase is regulated by the activation of PDGF-R via NOX-mediated ROS production and PDGF-R is also simultaneously regulated by the activation of Syk kinase. Src kinase is reportedly required for the full activation of PDGF-R and PDGF-associated signaling. 27, 28 In accor- dance with these results, we hypothesized that PDGF-BB initially stimulates Syk activity via NOX activity and that these consequently allow for the full activation of PDGF-R. As described above, the results of this study show that ROS scavenger and NOX inhibitors do not completely inhibit Syk phosphorylation in response to PDGF-BB. Our findings, therefore, suggest that Syk can be stimulated directly by PDGF-R without mediation via ROS-associated stimulation and imply that PDGF-BB stimulates Syk via both ROSdependent and independent pathways.
The migration of vascular smooth muscle cells is commonly known to be elevated by several factors, particularly PDGF. Previously, we determined that Syk inhibitors inhibit the PDGF-induced increase in vascular cell migration. 5 As described above, Syk activity was inhibited in the Ref-1-transfected cells as compared with the control cells. Moreover, the binding of Syk to PDGF-R as the result of PDGF treatment was also inhibited by transfection with Ref-1. Both Src and Syk have also been previously associated with PDGF-R, and this association appears to be a prerequisite for kinase activation. 3 We previously showed that the Src family kinase Lyn phosphorylates Syk and functions as an upper stream of Syk in rat mast cells. 29 Similarly, the Src inhibitor inhibited the PDGF-induced migration and phosphorylation of Syk. The activation of receptor tyrosine kinases, including PDGF-R, can result in Src and Syk activation, and these signals stimulate the elevation of MAPK phosphorylation. 30 PDGF is known to increase both MAPK activation and migration in several cells, which suggests that MAPK may be a crucial pathway in PDGF-mediated migration. In the present study, PDGF increased the phosphorylation of p38 MAPK and Hsp27 in RASMC. The results from previous reports demonstrated that p38 MAPK inhibitor and Hsp27-siRNA attenuate PDGF-induced migration in vascular smooth muscle cells. 
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Supplement Material Materials
Piceatannol was purchased from Tocris Bioscience (Bristol, UK). N-acetyl-cysteine (NAC) was acquired from Calbiochem (San Diego, CA). Diphenilene iodonium chloride (DPI), apocynin, NADPH, and lucigenin were from Sigma (St Louis, MO). 
Cell Migration and Proliferation Assay
The RASMCs were seeded in 96-well microtiter plates at a density of 2×10 3 cells per well. After various treatments for 24 hours, BrdU-labeling solution (10 µmol/L) was added to the cells, followed by 12 hours of incubation. The BrdU antibody complexes were detected using a Wallace 1420 VICTOR 3 TM luminometer (PerkinElmer, Boston, MA).
Superoxide Production
After various treatments, the RASMCs were lysed with tris buffer (50 mmol/L Tris, 150 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L PMSF, 1 mmol/L Na 3 VO 4 , 5 mmol/L NaF, 1% triton X-100, and 10% Glycerol, pH 7.2). The supernatant was treated with 10 µmol/L lucigenin and 500 µmol/L NADPH. After 5 minutes, its chemiluminescence was repeatedly measured using the luminometer over 20 minutes, at 2-minute intervals.
A single value was determined by the average of five readings at 20 minutes. Data normalization was applied to the total protein contents.
Aortic Ring Assay
The endothelium and adventitium of aorta obtained from Sprague Dawley rats (aged eight weeks, n = 8) were enzymatically removed, and the vessels were cut into rings 
